14th KUMAMOTO AIDS Seminar
 
 Poster Session
  Organizers: Yasuo Ariumi & Yorifumi Satou 
 
  Session I : 
  October 30th, Wednesday 13:00-15:00

Odd numbers 13:00-14:00 / Even numbers 14:00-15:00
  Session II :
  October 31st, Thursday 12:05-14:00
Free Time (Light snacks will be served)
[Program]  

 The poster numbers highlighted in blue make 1-minute presentation on 30th October.    
 The poster numbers highlighted in green make oral presentation on 31st October.
Poster No.
Presenter
Title
P-01
Kouki Matsuda
[Kumamoto Univ.]
Inhibition of HIV-1 entry by a tricyclic coumarin GUT-70
P-02
O-35-3B
Ryusho Kariya
[Kumamoto Univ.]
HAMLET and BAMLET induces cell death of Primary Effusion Lymphoma
P-03
Hiroki Goto
[Kumamoto Univ.]
Targeting IL-6 in the crosstalk between HIV-1 infection and primary effusion lymphoma
P-04
Eriko Kudo
[Kumamoto Univ.]
HIV-1 restriction factor, Murr1 (COMMD1), suppresses Toll-like receptor signaling in HIV-1 latently infected cells
P-05
Farzana Bhuyan
[Kumamoto Univ.]
Features of HIV-1 replication in fibrocytes, the recently identified target cells of HIV-1
P-06
O-18-3A
Md Abu Osman
[Kumamoto Univ.]
M-CSF diminishes anti-HIV-1 activity of cytokines including IL-32
P-07
Hesham E. Nasser
[Kumamoto Univ.]
Phenotypes of fibrocytes, the recently identified HIV-1 host cells
P-08
Michihiro Hashimoto
[Kumamoto Univ.]
The selective activation of anti-inflammatory M2-type macrophages by HIV-1 Nef is mediated by a serine/threonine kinase TAK1
P-09
Kodai Kawano
[Kumamoto Univ.]
HIV-1 suppresses LINE-1 retrotransposition
P-10
O-33-3B
Kazuhiko Maeda
[Kumamoto Univ.]
Role of mammalian TREX-2 component GANP in HIV-1 infection
P-11
Kazuaki Monde
[Kumamoto Univ.]
HERV-K Gag coassembles with HIV-1 Gag via its CA domain and changes morphology of HIV-1 particles to reduce the infectivity
P-12
Yusuke Nakano
[Kumamoto Univ.]
Preferential recognition of monomeric forms of CCR5 by HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1
P-13
Hiromi Terasawa
[Kumamoto Univ.]
Competitive resistance of a CXCR4-using HIV-1 lacking amino acid substitutions in the V3 loop of gp120 to a CXCR4 inhibitor AMD3100
P-14
Junko S Takeuchi
[Kyoto Univ.]
Quantification of HIV cell-free and cell-to-cell transmissions based on experimental-mathematical investigations
P-15
O-19-3A
Kristel Paola Ramirez Valdez
[Kumamoto Univ.]
Can antibodies contribute to controlling infection with transmitted/founder virus?
P-16
Kazuki Tanaka
[Kumamoto Univ.]
Miniaturization of antibodies against CD4-induced epitope on gp120
P-17
Yasuhiro Maruta
[Kumamoto Univ.]
Post-attachment neutralization as a mechanism of efficient activities of scFv from anti-V3 monoclonal antibody
P-18
O-34-3B
Muntasir Alam
[Kumamoto Univ.]
Effects of Enfuvirtide resistant mutations on the sensitivity to neutralizing antibodies
P-19
O-28-3B
Shohei Taketomi
[Tokyo Medical and Dental Univ.]
Structure activity relationship studies on a spacer moiety of small molecular CXCR4 antagonists as potent HIV-1 entry inhibitors
P-20
Yuki Hirota
[Tokyo Medical and Dental Univ.]
Indole-type small CD4 mimic molecules targeting an HIV envelope protein gp120
P-21
Shigeyoshi Harada
[NIID]
In vitro selection of bifunctional CD4 mimic small compounds (NBD analogues) using bulk and cloned primary isolates
P-22
Samatchaya Boonchawalit
[Kumamoto Univ.]
Analysis of relationships between Maraviroc (MVC) resistant mutations and sensitivity to antibody-mediated neutralization
P-23
O-29-3B
Masayuki Amano
[Kumamoto Univ.]
Discovery of small compounds which induce HIV-1 Capsid protein degradation
P-24
Tomofumi Nakamura
[Kumamoto Univ.]
Dynamics of IN multimerization and a potent modulation by allosteric HIV-1 integrase (IN) inhibitors in living cells using bimolecular fluorescence complementation (BiFC)
P-25
Joseph R. Campbell
[Kumamoto Univ.]
Accessing HIV-1 Integrase LEDGF Binding Inhibitors using bimolecular fluorescence complementation (BiFC)
P-26
Hiromi Ogata-Aoki
[Kumamoto Univ.]
Prophylactic administration of Raltegravir alters dynamics of HIVmC dissemination in huPBMC-transplanted NOJ mice
P-27
O-31-3B
Amber R. Moore
[Kumamoto Univ.]
Evaluation of HIV-1 reverse transcriptase (RT) heterodimerization within living cells using bimolecular fluorescence complementation (BiFC)
P-28
O-30-3B
Hironori Hayashi
[Kumamoto Univ.]
The dimerization inhibition mechanism of darunavir and the dynamics of HIV-1 protease dimerization
P-29
O-32-3B
Pedro Miguel Salcedo Gomez
[Kumamoto Univ.]
GRL-04810 and GRL-05010; novel difluoride-containing HIV-1 protease inhibitors (PIs) with potent antiviral activity and favorable penetration across the blood-brain barrier
P-30
Manabu Aoki
[Kumamoto Health Science Univ.]
Novel HIV-1 protease inhibitors, GRL-015, GRL-085, and GRL-097, potently inhibit the replication of multi-PI-resistant HIV-1s
P-31
O-27-3A
Takayuki Chikata
[Kumamoto Univ.]
Host-specific adaptation of HIV-1 subtype B in the Japanese population
P-32
O-22-3A
Xiaoming Sun
[Kumamoto Univ.]
Presentation of two HLA-A*24:02-restricted overlapping epitopes elicit different patterns of CD8 T cell repertoire and select same escape mutation in HIV-infected patients
P-33
O-21-3A
Nozomi Kuse
[Kumamoto Univ.]
Control of HIV-1 by Pol283-8-specific CTLs in HLA-B*51:01+long-term non progressors
P-34
Tomohiro Akahoshi
[Kumamoto Univ.]
Reversion of a CTL escape mutation by escape mutant-specific CTLs
P-35
Zhansong Lin
[Kumamoto Univ.]
Inhibition of human NK cell function by an HLA-Cw*12:02-restricted HIV-1 CTL epitope peptide and its escape mutant peptide
P-36
Tran Van Giang
[Kumamoto Univ.]
Establishment of a cohort of treatment-naive patients chronically infected with HIV-1 in Hanoi
P-37
O-25-3A
Keiko Sakai
[Kumamoto Univ.]
The lack of a significant impact of HIV-1 Gag replication capacities on patients’ disease outcomes in a chronically infected, treatment-naive Japanese cohort
P-38
Mohammad Arif Rahman
[Kumamoto Univ.]
Effect of protease inhibitor- and integrase inhibitor-resistant mutations on HIV-1-specific CTL recognition
P-39
O-24-3A
Macdonald Mahiti
[Kumamoto Univ.]
Differential modulation of Nef-mediated downregulation activity of HLA class I alleles in HIV-1 chronic infection
P-40
O-26-3A
Stanley C. Meribe
[Kumamoto Univ.]
Acceleration of disease Progression by a single naturally-arising polymorphism, within functional region of HIV-1 nef
P-41
Doreen Kamori
[Kumamoto Univ.]
HLA-A*02 allelic variants differently influence amino acid polymorphisms in an immunodominant epitope of HIV-1 Vpr
P-42
Mako Toyoda
[Kumamoto Univ.]
Analysis of naturally-occurring polymorphisms of HIV-1 Nef that impair CD4 down-regulation activity
P-43
O-20-3A
Chihiro Motozono
[Kinki Univ.]
Molecular basis of a dominant T cell response to an HIV reverse transcriptase epitope presented by the protective allele HLA-B*51:01
P-44
Hiroshi Ishii
[NIID]
Distinctive phenotype profiles of Env-specific CD8+ T cells in the chronic phase of SIV infection
P-45
O-23-3A
Koji Watanabe
[NCGM]
Cross-clade CD8+ T cell responses in chronically HIV-1 clade A/E-infected individuals
P-46
Manthana Mitchai
[Kumamoto Univ.]
HIV infection associated thrombocytopenia : a favourable clinical outcome in HAART therapy patient
P-47
O-36-3B
Junko Tanuma
[NCGM]
Stably low prevalence of drug resistant HIV transmission while antiretroviral therapy was scaling up in Southern Vietnam: 2008-2012
P-48
O-37-3B
Kazuhiro Matsuoka
[Nagoya Medical Center]
Cross-Resistance Mutation Patterns in Non-Nucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine in Clinical Isolates
P-49
Mayumi Imahashi
[Nagoya Medical Center]
Dissociation between insertion/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk: a population-based matched-cohort study in Japan
P-50
Takeshi Nishijima
[NCGM/ Kumamoto Univ.]
Incidence and risk factors for incident hepatitis C infection among men who have sex with men with HIV-1 infection in a large urban HIV clinic in Tokyo
P-51
Masahiro Ishikane
[NCGM]
Acute C hepatitis in Japanese HIV-infected patients in this decade
P-52
Daisuke Mizushima
[NCGM/ Kumamoto Univ.]
Clinical utility of quantitative cytomegalovirus DNA and its kinetics for predicting cytomegalovirus end-organ disease in HIV-infected patients
P-53
Fumihide Kanaya
[NCGM]
Monitoring of bone side effects during maraviroc containing treatment
P-54
Masaaki Toyama
[Kagoshima Univ.]
A tetrahydrotetramethylbenzophenanthridinone derivative selectively inhibits the proliferation of adult T-cell leukemia (ATL) cell lines in vitro
P-55
Yohann White
[University of the West Indies, Jamaica]
Impact of co-infection with human immunodeficiency virus type-1 and human T-cell lymphotropic virus type-1 on the latent HIV-1 reservoir in Jamaican patients with dual infection
 
Home (Japanese)
Home (English)
Center for AIDS Research HP